A medical practitioner with a strong inclination for compassion-driven research, Dr Aditi believes that ‘knowledge is a commodity to be shared’. She dedicates her time to simplifying complex medical information so people can develop a deeper understanding of their health and make informed choices.
Three-dimensional (3D) bioprinting is bringing about a paradigm shift in personalised medicine in the 21st century. According to a report by Mordor Intelligence (1), the global 3D bioprinting market was valued at USD 724.17 million in 2020 and is expected to reach USD 2398.27 million by 2026, growing at a CAGR of 21.91% over the forecast period (2021-2026). It has been predicted that the Asia-Pacific region has the highest scope for growth due to present demands (2). There’s presently an overwhelming demand for donated organs. However, it takes a long time to get an organ
A major obstacle to cancer immunotherapy is overcoming tolerance to ‘self-antigens’. While the immune responses against foreign antigens are not susceptible to self-tolerance, those mounted against tumour-associated self-antigens are subject to suppression by central or peripheral tolerance mechanisms (1). In humans, T-cell receptors (TCRs) that recognize self-tumour antigens have a lower affinity for the major histocompatibility complex (MHC): peptide complexes, compared to their virus-specific TCR counterparts, due to the thymic elimination of high-affinity TCRs. Thus, the endogenous T-cell activity is inadequate for the control of cancer (1). Tumours are frequently invaded by immune cells as
There are approximately 44 million people worldwide living with Alzheimer’s disease or a related form of dementia (1). The WHO has estimated that the number of individuals with dementia around the world will increase to 78 million and 139 million by 2030 and 2050 respectively(2). Due to its population size, South Asia, especially India, will be a major contributor to this increase (3). In India, currently more than 4 million people have some form of dementia (4). The main risk factor for Alzheimer’s disease (AD) is ageing. A study done by The National Institute on
A 2022 study found that India is home to approximately 5 million blind people and 70 million visually impaired people. Read on to know the causes, symptoms, risk factors, diagnosis, and treatment of blindness and visual impairment. What is blindness? What is visual impairment? Strictly speaking, blindness refers to the inability to perceive light. However, in general terms, we refer to blindness as the loss of vision. In contrast, visual impairment refers to a decrease in vision that cannot be corrected by traditional methods such as spectacles. What is visual acuity? Visual acuity measures how
Paget’s disease of the bone, while a frequent occurrence in Western countries, is still quite uncommon in India. Read on to learn what Paget’s disease is, how it occurs, and its diagnosis, treatment, complications, and prevention. What is Paget’s disease of the bone? Paget’s disease of the bone (or osteitis deformans) is a condition where the normal process of bone remodelling is disrupted, causing bones to become weak, brittle, and spongy. It most commonly affects the tibia (shin bone), although it can also affect the spine, hips, skull bone etc. What happens in Paget’s disease?
India, the ‘diabetes capital of the world’, is home to around 77 million diabetics, out of which 25% of them develop diabetic foot disease. Find out what it is, how it’s caused, what its risk factors are along with its symptoms, diagnosis and management. What is diabetic foot? Simply put, diabetic foot is the spectrum of conditions occurring as a consequence of diabetes that affects your feet. Diabetes, especially when left untreated, can lead to a multitude of serious complications. When your blood glucose levels are very high, they cause damage to your nerves and